Riskpilot← Back to searchSign inGet full accessSanClinic AB
ABActiveOrg 5594265851Takpannevägen 192Beauty care and other beauty treatment activities · NACE 9622Est. 20231 employees
Revenue 2025
SEK 1,7M
+87% vs 2024
EBITDA margin
2.6%
+130% vs 2024
Equity ratio
14.4%
Financial strength
Net profit 2025
SEK 15K
+670% vs 2024
| Revenue | SEK 1,7M | +87% |
| EBITDA | SEK 43K | +130% |
| Net profit | SEK 15K | +670% |
| Total assets | SEK 345K | +135% |
| Equity | SEK 50K | +43% |
| Employees | 1 | — |
Legal name
SanClinic AB
Org number
5594265851
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
16 mars 2023
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet skönhetsbehandlingar, kemisk peeling, kosmetisk tatuering, tandblekning, hudvård och trådlyft, fransförlängning. Samt därmed förenlig verksamhet.
Address
Takpannevägen 192
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 600 | 902 | 1 685 |
| Staff expenses | −239 | −207 | −487 |
| EBITDA | 10 | 19 | 43 |
| Depreciation & amort. | — | — | −13 |
| EBIT | 10 | 19 | 30 |
| Net financials | −0 | −16 | −11 |
| Profit before tax | 10 | 2 | 19 |
| Tax | −2 | −0 | −4 |
| Net profit | 8 | 2 | 15 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 82 | 147 | 345 |
| Equity | 33 | 35 | 50 |
| Long-term debt | −31 | 100 | 237 |
| Short-term debt | 81 | 12 | 58 |
| Total debt | 50 | 112 | 295 |
EBITDA margin
2.6%
This company
15.8%
Market median
-84% vs market
20232025
Equity ratio
14.4%
This company
38.2%
Market median
-62% vs market
20232025
Return on equity
30.1%
This company
18.4%
Market median
+64% vs market
20232025
Net profit margin
0.9%
This company
8.1%
Market median
-89% vs market
20232025
Asset turnover
4.89×
This company
1.12×
Market median
+337% vs market
20232025
Debt / equity
5.95×
This company
0.62×
Market median
-860% vs market
20232025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2023 | |
| Board of Directors | 2023 | |
| Former (3) | ||
| Deputy Board Member | 2023 – 2023 | |
| Deputy Board Member | 2023 – 2023 | |
| Board of Directors | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SanClinic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alaa Abuelalaa Elhag Mohamed | Deputy Board Member | 0 companies |
| Sanaa Nasereldein Mohamed Yagoub | Board of Directors | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Erik Alexander Stötsberg | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |